QuiVad

Home / Netherlands / Lakefront Biotherapeutics NV

Lakefront Biotherapeutics NV

No short position is open on this share today.

Follow

Evolution of the disclosed total

0%1%2%3%
Oct 2025Jan 2026Apr 2026Jul 2026
Sum of open short positions, asĀ % of capital. Hover or tap the curve to see which funds make it up.
Over the whole history, the total peaked at 5.00% on May 21, 2018. The shaded band matches the twelve months of the first chart.

July 31, 2015 today

Open positions

No fund discloses a short position on this share today. The History of disclosures table lists the ones that existed.

Follow by RSS

Get the moves on Lakefront Biotherapeutics NV by mail.

There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.

History of disclosures

689 disclosures on record for this share.
DateFund% of capitalEnd of publication
July 17, 2019Marshall Wace LLP0.69%
July 15, 2019Marshall Wace LLP0.71%
July 4, 2019Citadel Advisors LLC0.49%
July 2, 2019Citadel Advisors LLC0.56%
June 27, 2019Marshall Wace LLP1.00%
June 21, 2019Citadel Advisors LLC0.68%
June 19, 2019Marshall Wace LLP0.97%
June 17, 2019Citadel Advisors LLC0.79%
June 13, 2019Citadel Advisors LLC0.80%
June 11, 2019Marshall Wace LLP0.80%
June 11, 2019Citadel Advisors LLC0.79%
June 10, 2019AQR Capital Management, LLC1.98%
June 7, 2019Citadel Advisors LLC0.80%
June 7, 2019Marshall Wace LLP0.71%
June 3, 2019AQR Capital Management, LLC2.00%
May 31, 2019Marshall Wace LLP0.60%
May 20, 2019Marshall Wace LLP0.51%
May 15, 2019AQR Capital Management, LLC1.92%
May 15, 2019Citadel Advisors LLC0.79%
April 25, 2019AQR Capital Management, LLC1.80%
April 17, 2019Citadel Advisors LLC0.82%
April 15, 2019AQR Capital Management, LLC1.76%
April 8, 2019AQR Capital Management, LLC1.69%
April 5, 2019Citadel Advisors LLC0.78%
April 3, 2019Citadel Advisors LLC0.80%
March 29, 2019Citadel Advisors LLC0.76%
February 22, 2019AQR Capital Management, LLC1.70%
February 21, 2019AQR Capital Management, LLC1.69%
February 20, 2019AQR Capital Management, LLC1.70%
January 11, 2019AQR Capital Management, LLC1.69%
January 10, 2019AQR Capital Management, LLC1.70%
January 9, 2019AQR Capital Management, LLC1.69%
January 8, 2019AQR Capital Management, LLC1.70%
November 30, 2018AQR Capital Management, LLC1.68%
November 13, 2018Balyasny Asset Management LP0.47%
November 12, 2018Balyasny Asset Management LP0.51%
October 2, 2018AQR Capital Management, LLC1.79%
September 18, 2018AQR Capital Management, LLC1.85%
September 17, 2018AQR Capital Management, LLC1.92%
September 13, 2018AQR Capital Management, LLC2.03%
September 11, 2018AQR Capital Management, LLC2.10%
September 7, 2018AQR Capital Management, LLC2.09%
August 31, 2018AQR Capital Management, LLC2.16%
August 16, 2018Marshall Wace LLP0.46%
August 15, 2018AQR Capital Management, LLC2.29%
July 30, 2018WorldQuant, LLC0.47%
July 26, 2018Marshall Wace LLP0.52%
July 20, 2018AQR Capital Management, LLC2.39%
July 19, 2018Marshall Wace LLP0.37%
July 17, 2018Marshall Wace LLP0.50%

Download 689 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats

Other companies sold short in the Netherlands

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Lakefront Biotherapeutics NV, source AFM, data as at April 2, 2026, https://www.quivad.com/action/lakefront-biotherapeutics-nv?page=9